2. Nearly a decade ago, TECHLAB developed a marketing and sales
partnership with Alere. Part of our agreement was for Alere to develop and
represent TECHLAB products within their global branding infrastructure.
Upon further evaluation, TECHLAB came to realize that our company
was missing out on the value of building and maintaining our own brand
identity, both at the product and corporate levels. With this revelation came
a new commitment to investing resources into building our brands and
telling our stories through our own voice, rooted in science, research, and
development and speaking directly to our core audience of clinicians and
physicians. Since 2014, TECHLAB has put significantly increased energy
into reclaiming our branding and marketing efforts.
This publication presents TECHLAB’s recent brand development and
marketing work and is organized by product category. As we do with our
diagnostics, we test the results of our marketing and continue to refine and
enhance these efforts to deliver ever improving results.
Believing in the Value of
Investing in our Brands
3. From ads to selling aids, TECHLAB has built a powerful marketing engine
to support its superior technology. TECHLAB Marketing is responsible for
identifying, anticipating, and satisfying customer requirements. The goals of
our marketing efforts are to:
• Raise product awareness
• Generate product interest
• Build product desire
• Facilitate product sales, and
• Measure results for improved effectiveness
TECHLAB yields measurable results with market share gain, customer
retention, brand awareness, loyalty, and trust through multi-channel
marketing strategies and tactics. These channels largely include e-mail
marketing, print collateral, direct mail, web marketing, tradeshows,
advertising, and public relations.
Powerful Marketing Tools
for Superior Diagnostics
Multi-Channel
Marketing
PUBLIC
RELATIONS
E-MAIL
MARKETING
PRINT
COLLATERAL/
DIRECT MAIL
ADVERTISING
TRADESHOW
WEB
7. Register
HEREto get your
IBD-SCAN®
or IBD EZ VUE®
Evaluation
Test Kit!
IBD-SCAN® IBD EZ VUE®This voucher is redeemable for one
IBD-SCAN®
OR one IBD EZ VUE®
lactoferrin evaluation test kit.
Check the circle on the kit of your choice.
Limit 1 test kit per facility. Facility must be licensed
to perform moderate or high complexity testing.
This voucher is not redeemable for cash.
This voucher expires on December 31, 2014.
| Lactoferrin Test KitVOUCHER
OR
Quantitative Assay Rapid Qualitative Assay
DDW2014
See reverse for
how to redeem
PROMO CODE
8. 2001 Kraft Drive | Blacksburg, VA 24060 | USA
Get a reliable
indication of
intestinal
inflammation
with lactoferrin
testing.
www.techlab.com
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
Find out how
INSIDE!
Is it IBS or
IBD?
Take the proactive approach
to identify the condition.
Get a reliable indication of intestinal
inflammation with lactoferrin testing.
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
www.techlab.com
is it IBS?
Take the proactive approach
to identify the condition.
Get a reliable indication of intestinal
inflammation with lactoferrin testing.
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
www.techlab.com
or is it IBD?
After the show, TECHLAB sent
booth visitors a special mailing
containing expanded information
on lactoferrin and a fun,
promotional item.
AN ENGAGING ENVELOPE enticed
recipients to open it.
A REMOVABLE HOLOGRAM MAGNET
attached to the front of a brochure
changed images and wording upon tilting
to compellingly illustrate the question that
lactoferrin testing helps to answer.
A MULTI-PAGE BROCHURE provided
detailed information on how lactoferrin
testing works, its clinical advantages,
how to order testing, and scientific
publications on lactoferrin. The
brochure cover and a sample interior
spread are shown here.
9. There are ample national and
international publications on
the effectiveness of lactoferrin
as a biomarker of inflammation.
Here are just a few examples.
What evidence-based literature exists on lactoferrin?
S. Kane, W. Sandborn, P. Rufo, A. Zholudev, J. Boone, D.
Lyerly, M. Camilleri, and S. Hanauer.
Fecal lactoferrin is a sensitive and specific
marker in identifying intestinal inflammation.
2003. Am J Gastroenterol 98:6. 1309-1314.
M. Parsi, B. Shen, J. Achkar, F. Remzi, J. Goldblum, J.
Boone, D. Lin, J. Connor, V. Fazio, and B. Lashner.
Fecal lactoferrin for diagnosis of symptomatic
patients with ileal pouch-anal anastomosis.
2004. Gastroenterology 126. 1280-1286.
T. Walker, M. Land, A. Kartashov, T. Saslowsky, D. Lyerly,
J. Boone, and P. Rufo.
Fecal lactoferrin is a sensitive and specific marker
of disease activity in children and young adults
with inflammatory bowel disease.
2007. J Pediatr Gastroenterol Nutr 44:4. 414-422.
R. Sidhu, P. Wilson, A. Wright, C. Yau, F. D’Cruz, L. Foye,
S. Morley, A. Lobo, M. Mcalindon and D. Sanders.
Faecal lactoferrin—a novel test to differentiate
between the irritable and inflamed bowel?
2010. Aliment Pharmacol Ther 31. 1365-1370.
J. Däbritz, J. Musci, and D. Foell.
Diagnostic utility of faecal biomarkers in patients
with irritable bowel syndrome.
2014. World Journal of Gastroenterol 20:2. 363-375.
Take the proactive approach
to identify the condition.
Does your patient suffer
from abdominal pain?
Get a reliable indication of intestinal
inflammation with lactoferrin testing.
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
www.techlab.com
14. In early 2015, TECHLAB’s marketing team created a new campaign
messaging and visual communications strategy for lactoferrin testing
products based upon market research findings, choosing to promote
“lactoferrin testing” as a brand in and of itself rather than merely promoting
the individual lactoferrin products. This new approach allowed us to focus
on the application of lactoferrin testing to new markets, such as physicians
working with Clostridium difficile (CDI) patients, whereas previously the
focus had been limited to IBD and IBS. TECHLAB’s marketing team
positioned lactoferrin testing in the market as the reliable choice for getting
a first read on intestinal inflammation.
As the only FDA-approved lactoferrin-based tests for intestinal
inflammation, TECHLAB moved to capitalize on our unique market position
by launching a rebrand of our IBD products. We first chose to rename the
products to more prominently feature the lactoferrin biomarker. We also
took the opportunity to completely redesign our packaging, establishing a
strong, cohesive visual identity for the lactoferrin product line.
Lactoferrin Testing
2015 Campaign
PRODUCT REBRANDING
REDESIGNED KIT BOXES visually
unite lactoferrin products with color and
shape while maintaining some product
differentiators.
REBRANDED TEST CASSETTES
in the case of the lateral flow format
display the new name.
UPDATED INSTRUCTION CARDS
inside the kit boxes make use of the
new visual identity.
A DESIGNATED WEBSITE just for
lactoferrin testing allows us to put our
new messaging on-line.
REBRAND ANNOUNCEMENTS sent
to all of our customers alerted them to
the changing look and built anticipation
for the new products.
18. As a result of our lactoferrin
marketing campaign, product
sales increased by 10% in
2015 over 2014.
19. A FUN CONTEST where delegates
had to guess the number of little
TECHLAB toilets in a huge container
displayed in the main exhibition hall was
met with great enthusiasm.
OUR 30-FOOT BOOTH was a show
standout and drew big crowds each
day. Four connected video screens
presented lactoferrin testing information
above large lightbox displays. A
demonstration counter featured direct
access to the lactoferrin testing
website, allowing booth visitors to
explore the site on their own. The main
counter held various support collateral
pieces that TECHLAB staff used to
further explain the products and that
visitors could then take away with
them in their lactoferrin testing branded
bags. The back wall and coffee table
displayed the newly rebranded test kit
boxes, allowing staff easy access to
them to show prospective clients.
Our new campaign
generated a record
number of new
leads at DDW—
more than double
that of the previous
year.
20. A FOURTEEN-PAGE BROCHURE
included in the DDW registration
welcome bag and also made available
at the booth provided an overview
of lactoferrin testing, its clinical
advantages, types of testing formats
available, and ordering tips.
LARGE, COLORFUL BAGS sporting
the lactoferrin branding were given out
at the booth to hold all of the lactoferrin
collateral. The large bag size allowed it
to also carry show collateral from other
booths, resulting in our bag becoming
the most visible carryall at the show.
NON-INVASIVE ∙ SENSITIVE ∙ SPECIFIC ∙ COST-EFFECTIVE
Get a reliable first read on intestinal inflammation with
LACTOFERRIN TESTING
lactoferrintesting.com
IBS
IBD
CDI
Assists in the diagnosis
and monitoring of
24. Visit us at ASTMH 2014 BOOTH 113
Infectious Disease
DIAGNOSTICS FOR GLOBAL HEALTH
RAPID RESULTS • HIGH SENSITIVITY • HIGH SPECIFICITY
E. HISTOLYTICA
QUIK CHEK™
The first rapid test
to distinguish E.
histolytica from non-
pathogenic E. dispar
GIARDIA/
CRYPTOSPORIDIUM
QUIK CHEK
Highly sensitive detection
of the two most common
waterborne intestinal
parasites from a single
fecal sample
SHIGA TOXIN
QUIK CHEK
The only rapid test
able to detect Shiga
toxin-producing E. coli/
verotoxin-producing
E. coli directly from
fecal samples
LEUKO EZ VUE®
Accurate,
non-subjective
laboratory results for
fecal lactoferrin and
intestinal inflammation
Distributed by: Developed & manufactured by:
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
www.techlab.com
,
Infectious Disease
DIAGNOSTICS FOR GLOBAL HEALTH
E. HISTOLYTICA
QUIK CHEK™
The first rapid test
to distinguish E.
histolytica from non-
pathogenic E. dispar
GIARDIA/
CRYPTOSPORIDIUM
QUIK CHEK
Highly sensitive detection
of the two most common
waterborne intestinal
parasites from a single
fecal sample
SHIGA TOXIN
QUIK CHEK
The only rapid test
able to detect Shiga
toxin-producing E. coli/
verotoxin-producing
E. coli directly from
fecal samples
LEUKO EZ VUE®
Accurate,
non-subjective
laboratory results for
fecal lactoferrin and
intestinal inflammation
E. HISTOLYTICA
E. HISTOLYTICA
Enteric
Diagnostics
Malnutrition
Intestinal
Inflammation
Multiplex
Screening
Traveler
Health
Rapid
Results
GIARDIA/CRYPTO
High
Sensitivity
GIARDIA/CRYPTO SHIGA TOXIN
SHIGA TOXIN
High
Specificity
LEUKO EZ VUE
LEUKO EZ VUE
Infectious
Disease
DIAGNOSTICS
FOR GLOBAL
HEALTH
ASTMH
2014 Tradeshow
To appeal to the international
audience at ASTMH, TECHLAB
featured four of our rapid QUIK
CHEK™ and lateral flow test kits
for infectious disease and touted
our international collaborations.
25. TECHLAB®
, Inc. partners with health research organizations to make our products avail-
able for clinical and epidemiological studies of diarrheal diseases.
Bill & Melinda Gates Foundation
With a grant from the Bill & Melinda Gates Foundation, the University of Maryland School
of Medicine’s Center for Vaccine Development used TECHLAB diagnostics for a three-
year study of diarrheal diseases among young children in developing areas of Africa and
Asia. The Global Enteric Multi-Center Study (GEMS) is the most extensive study of child-
hood diarrheal diseases ever conducted, with more than 22,000 subjects from seven
sites. Researchers evaluated approximately 40 pathogens to determine the most com-
mon causes of moderate-to-severe diarrheal disease.
National Institutes of Health (NIH)
Using small business grants obtained through the National Institute of Allergy and Infec-
tious Diseases (NIAID) and the Middle Atlantic Center of Excellence (MARCE), TECHLAB
and its research collaborators have effectively moved medical diagnostics from concept
to the international marketplace. TECHLAB has partnered over the past 15 years with Dr.
William A. Petri, Jr. at the University of Virginia and Dr. Rashidul Haque at the International
Centre for Diarrhoeal Disease Research in Bangladesh to secure NIH development funds
for global diagnostics.
TECHLAB strives to build long-term partnerships that create successful outcomes lead-
ing to better patient healthcare.
TECHLAB Senior Research Scientist, Dr. Joel Herbein, visits Bamako, Mali to lead enteric
parasitology diagnostic training at the Center for Vaccine Development Mali study site.
Infectious Disease
COLLABORATIONS THAT SUCCEED
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
POSTCARD MAILERS sent to likely
show participants before the show
promoted the products to be featured
and invited participants to the booth.
A CUSTOM DESIGNED 20-FOOT
BOOTH provided an integrated video
monitor and numerous product and
information display areas.
VIDEOS detailing our products and our
work in developing countries played
continuously at the booth.
SIGNAGE greeted counter visitors
and told the story of TECHLAB’s
collaboration with both the Bill &
Melinda Gates Foundation and NIH.
PRODUCT DEMONSTRATION
VIDEOS detailing the correct use of
each test kit could be viewed at the
booth and also on-line after.
FOLLOW-UP EMAILS sent after the
show to booth visitors helped to remind
participants of TECHLAB products
and provide convenient on-line links to
ordering information.
26.
27. ECCMID
2015 Tradeshow
TECHLAB focused on promoting
our QUIK CHEK™ product
portfolio for infectious disease at
the 2015 ECCMID tradeshow. We
chose “Rapid, high-performance
diagnostics for global health” as
our main marketing message.
We custom-built a brand new,
30-foot with two QUIK CHEK™
cassette shapes flanking an
enormous video wall. The booth
also featured two free-standing
lightboxes that displayed product
messaging and test kit boxes,
a product demonstration video
counter, a reception counter
holding printed collateral, a
seating area, and fun, branded
giveaway items.
28. RENDIMIENTO PROBADO EN EL
DIAGNÓSTICO DE ENFERMEDADES GASTROINTESTINALES
¿Hasta qué punto es equiparable la tecnología de
ELISA rápida de QUIK CHEK™ con el flujo lateral?
frente a
QUIK CHEK™
| Flujo lateral
ELISA rápida:
QUIK CHECK™
Flujo lateral
Proceso El contacto entre una
almohadilla y una
membrana porosas permite
la difusión eficiente y la
formación de complejos
antígeno-anticuerpo.
Mediante la detección
enzimática se logra un
aumento de la sensibilidad.
Los antígenos interactúan
con los anticuerpos fijados
al látex o a las partículas de
oro que se capturan en la
línea de prueba para formar
una línea coloreada.
¿Es necesario
un flujo
uniforme?
No Sí
¿Hasta qué
punto son
fiables los
resultados?
Un paso de lavado
garantiza que el material no
unido se retire de la línea de
prueba, lo que reduce las
interferencias y amplifica el
resultado de la prueba.
Sin el paso de lavado, el
material no unido no puede
retirarse de la línea de
prueba, lo que da lugar a
una prueba supeditada a
obstrucciones que arroja
resultados imprecisos o no
concluyentes.
How does QUIK CHEK™
rapid ELISA
technology compare to lateral flow?
What is
the process?
Does it
require a
uniform flow?
How reliable
are results?
QUIK CHEK™
Contact between a porous
pad and a porous mem-
brane enable the efficient
diffusion and formation
of antigen-antibody
complexes. Increased
sensitivity is achieved
by enzymatic detection.
No
A wash step ensures
unbound material is
removed from the test
line, minimizing interfer-
ence and amplifying
the test result.
Lateral Flow
Antigens interact
with antibodies attached
to latex or gold particles
that are captured
at the test line to form
a colored line.
Yes
With no wash step,
unbound material may not
be removed from the test
line, leaving the test
subject to clogs
that result in inconclusive
or inaccurate results.
QUIK CHEK™
| Lateral Flow
vs
A HANDY COMPARISON CARD
produced in both English and Spanish
explained the differences between QUIK
CHEK™ and lateral flow technologies.
A VIDEO playing continuously at the
booth also explored the differences
between QUIK CHEK™ and lateral flow
technologies with clever animations.
29. Rapid, High-Performance Diagnostics for Global Health
QUIK CHEK™
Distributed by:
Developed and Manufactured by:
Literature List
Data from package insert (n=1126). Further testing may assist diagnosis.
A COMPREHENSIVE
Algorithm for C. difficile Testing
+ LACTOFERRIN
TESTING
for Inflammation
www.techlab.com
Testing Algorithm
C. DIFF QUIK CHEK COMPLETE®
13%
GDH +
Toxin +
77%
GDH -
Toxin -
LACTOFERRIN TESTING
FOR INFLAMMATION
TO DETERMINE SEVERITY
10%
GDH +
Toxin -
90% of samples
“Diarrhea and the presence of C. difficile in the stool are associated
with intestinal inflammation, as detected by fecal lactoferrin.”
L.R. Archbald-Pannone, J.E. Sevilleja, R.L. Guerrant.
Diarrhea, Clostridium difficile, and intestinal inflammation in residents of a
long-term care facility.
2010. J Am Med Dir Assoc. 11 (4): 263-7
“In conclusion, CDI PCR-positive patients with 027 infection and stool
toxin have increased lactoferrin and are at increased risk of death.”
J.H. Boone, L.R. Archibald-Pannone, K.N. Wickham, R.J. Carman, R.L.
Guerrant, C.T. Franck, D.M. Lyerly.
Ribotype 027 Clostridium difficile infections with measurable stool toxin
have increased lactoferrin and are associated with a higher mortality.
2014. Eur J Clin Microbial Infect Dis. 33 (6): 1045-51
“Our findings show that elevated lactoferrin, along with increased WBC
count and low serum albumin, were associated with more severe CDI.”
J.H. Boone, J.R. DiPersio, M.J. Tan, S.J. Salstrom, K.N. Wickham, R.J.
Carman, H.R. Totty, R.E. Albert, D.M. Lyerly.
Elevated lactoferrin is associated with moderate to servere Clostridium
difficile disease, stool toxin, and 027 infections.
2013. Eur J Clin Microbiol Infect Dis. 32: 1517 – 1523
“Differences in fecal lactoferrin levels suggest variable presence or
severity of C. difficile infection among toxin+ and toxin- patients.”
P.R. LaSala, T. Eckhmimi, A.K. Hill, I. Farooqi, P.L. Perrotta.
Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium
difficile specimens.
2012. J. Clin Microbiol. DOI:10.1128/JCM.02735-12
“Lactoferrin appears to be a useful marker for the presence of
inflammatory diarrhea.”
M.W.D. Wren, M. Sivapalan, R. Kinson, N.P. Shetty.
Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests
for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic
culture in the diagnostics laboratory.
2008. Br J Biomed Sci. 661 (1): 1-5
“We report that higher levels of intestinal inflammation, as measured
by quantitative fecal lactoferrin, are associated with moxifloxacin-
resistant CDI.”
S.W. Pawlowski, L. Archbald-Pannone, R.J. Carman, C. Alcantara-Warren,
D. Lyerly, C.W. Genheimer, D.N. Gerding, R.L. Guerrant.
Elevated levels of intestinal inflammation in Clostridium difficile infection
associated with fluoroquinolone-resistant C. difficile.
2009. J Hosp Infect. 73 (2): 185-187.
“Fecal interleukin (IL)-8 and lactoferrin are also elevated in vivo, in
patients with severe CDI.”
R.E. El Feghaly, J.L. Stauber, E. Deych, C. Gonzalez, P.l. Tarr, D.B. Haslam.
Markers of intestinal inflammation, not bacterial burden, correlate with
clinical outcomes in Clostridium difficile infection.
2013. Clinical Infectious Diseases 56 (12): 1713-21
Session O062: Severity and outcome
parameters of Clostridium difficile
infections based on toxin, toxin-
gene and lactoferrin testing in stools.
Presentation is scheduled for the oral
session Pioneering diagnostics:
beyond genomics and MALDI-TOF
Date and Time: 26 April 2015
from 11:42am-11:54am
Venue: Hall F
Presenter: Lutz Von Mueller
ePoster EV0544: Evaluation of the
new SHIGA TOXIN QUIK CHEK™
membrane enzyme immunoassay for
the direct detection of STEC in stool
specimens and enrichment broth
Authors: Eigner Ulrich, Anke
Veldenzer, Rosemarie Schwarz,
Martin Holfelder
Viewing Station: Diagnostic/laboratory
methods other than molecular
ePoster LBEV0584a: Evaluation of
E. HISTOLYTICA QUIK CHEK™: The
first rapid diagnostic test specific
for the detection of pathogenic
Entamoeba histolytica in human
faecal specimens
Authors: Hencke, Verkerke, Siddique,
Hanbury, Haque, Petri, Herbein
Viewing Station: Diagnostic/laboratory
methods other than molecular
KEY SESSIONS
& ePOSTERS
Rapid, High-Performance Diagnostics for Global Health
QUIK CHEK™
MULTI PURPOSE BOOKMARKS
designed for insertion in the exhibit
guide provided both information on
TECHLAB’s key sessions and e-posters
and useful lined space for notes on the
reverse side.
PRODUCT INFORMATION SHEETS
showing a comprehensive algorithm
for C. difficile testing through the
combined use of C. DIFF QUIK CHEK
COMPLETE®
and lactoferrin testing
were given out at the booth.
A BRANDED DANCING ROBOT
giveaway item proved to be a huge
crowd pleaser and drew many people
to the booth via word of mouth from
other booth visitors.
LARGE, BRANDED BAGS provided
great exposure to our show messaging
as participants carried it throughout the
exhibit hall.
30. PROJECT
TECHLAB 10x30 ASM exhibit concept - view 1
ASM
2015 Tradeshow
At the 2015 ASM tradeshow,
TECHLAB promoted four of our
rapid QUIK CHEK™ and lateral
flow test kits for infectious disease
at our booth and highlighted
SHIGA TOXIN QUIK CHEK™ in
our marketing collateral.
A CUSTOM DESIGNED 30-FOOT
BOOTH had a four-screen integrated
video display, large panels for product
messaging, an attractive seating area,
and a welcome counter designed
to hold printed collateral pieces and
touchscreen displays.
POSTCARD MAILERS sent to expected
show participants ahead of the show
promoted the comparative advantages
of SHIGA TOXIN QUIK CHEK™ over
the competitor and promoted our booth
number and website.
PRODUCT SELL SHEETS were
available at the booth to take away.
LARGE, BRANDED BAGS given out
at the booth held our collateral and also
collateral from other booths.
A FOUR-SCREEN VIDEO played
continuously at the booth, detailing
product features and benefits.
31. Infectious Disease?
Better to Know Earlier.
Broth culture results that are twice as sensitive
SHIGA TOXIN QUIK CHEK™
Don’t doubt your STEC broth culture result. Detect more true positives with the
TECHLAB®
SHIGA TOXIN QUIK CHEK™ test.
SHIGA TOXIN QUIK CHEK™
SHIGA TOXIN
QUIK CHEK™
Leading
EHEC Test
85.0%1
100.0%1
35.3%2
54.5%2
Clinical Sensitivity
Positive Predictive Value
The above clinical results were obtained by testing broth cultures and comparison to real-time PCR.
REFERENCES:
1
L. Chui, L. Patterson-Fortin, J. Kuo, V. Li, V. Boras. 2015. Evaluation of enzyme immunoassays and real-time PCR for detecting Shiga toxin-
producing Escherichia coli in Southern Alberta, Canada. J Clin Microbiol. 53(3):1019-23.
2
L. Chui, M.C. Lee, R. Allen, A. Bryks, L. Haines, V. Boras. 2013. Comparisons between ImmunoCard STAT!®
and real-time PCR as screening tools for
both O157:H7 and non-O157 Shiga toxin-producing Escherichia coli in Southern Alberta, Canada. Diagn Microbiol Infect Dis. 77(1):8-13.
Distributed by:
Developed & Manufactured by:
Find out more at techlab.com
asm2015 | BOOTH 752
Broth culture results that are twice as sensitive
SHIGA TOXIN QUIK CHEK™
Don’t doubt your STEC broth culture result.
Detect more true positives with the TECHLAB®
SHIGA TOXIN QUIK CHEK™ test.
SHIGA TOXIN QUIK CHEK™
Distributed by:
Developed & Manufactured by:
The Enterics Suite of Rapid Diagnostics
Broth culture results that are twice as sensitive
For more information or to order, contact your Cardinal Health sales
representative, call 1-800-964-5227 or visit cardinalhealth.com
SHIGA TOXIN QUIK CHEK™
REFERENCES:
1
L. Chui, L. Patterson-Fortin, J. Kuo, V. Li, V. Boras. 2015. Evaluation of enzyme
immunoassays and real-time PCR for detecting Shiga toxin-producing Escherichia coli
in Southern Alberta, Canada. J Clin Microbiol. 53(3):1019-23.
2
L. Chui, M.C. Lee, R. Allen, A. Bryks, L. Haines, V. Boras. 2013. Comparisons
between ImmunoCard STAT!®
and real-time PCR as screening tools for both O157:H7
and non-O157 Shiga toxin-producing Escherichia coli in Southern Alberta, Canada.
Diagn Microbiol Infect Dis. 77(1):8-13.
Don’t doubt your STEC broth culture result. Detect more true positives with the
TECHLAB®
SHIGA TOXIN QUIK CHEK™ test.
SHIGA TOXIN
QUIK CHEK™
Leading
EHEC Test
85.0%1
100.0%1
35.3%2
54.5%2
Clinical Sensitivity
Positive Predictive Value
SHIGA TOXIN QUIK CHEK™
The above clinical results were obtained by testing broth cultures and comparison to real-time PCR.
34. A website is a crucial component to any business. Prospective clients,
employees, and partners make critical decisions about whether to
work with a company using just the information provided on a website.
TECHLAB’s site is comprehensive and covers all aspects of our business.
Our website offers:
• Clear, comprehensive information
about our products and a variety of
purchasing options.
• A comprehensive digital library of
current clinical data and research.
• Information about the services
we provide beyond developing
diagnostic tests, like research
testing and medical device
manufacturing.
• Demonstrations of the innovations
we make in the diagnosis of
intestinal diseases.
Corporate Website
35. TECHLAB produces a quick
product reference guide that
allows laboratory and clinical
professionals easy access to
important information about our
complete product line.
OUR PRODUCT CATALOG is organized
to maximize the quick identification of
essential information about each test
we offer, including broad category
of diagnostic kit, catalog number,
suggested CPT code, number of tests
per kit, analytes detected, format, time
to results, and specimen requirements.
It is an invaluable sales tool.
Catalog
36. SPRING
2014
SPECIAL
25TH
ANNIVERSARY
ISSUE
An irregular publication of TECHLAB,® Inc.
dedicated to the etiology, diagnosis, and
therapy of diarrheal diseases and related
aspects of intestinal ecology
INSIDE
Experts Weigh In on Fecal Lactoferrin
Taking on the Challenge of C. Diff
Testing for the Big 3 Parasites
Detecting Shiga Toxin
…and more
PLUS our ever
popular stool notes
Brought to you by the makers of the
enteric suite of rapid diagnostics
C
LEUKO EZ VUE
T
C
LEUKO EZ VUE
T
C
Ag Tox
C. DIFF COMPLETE
C
Ag Tox
C. DIFF COMPLETE
C
Cryp Giar
QUIK CHEK
C
Cryp Giar
QUIK CHEK
C
1 2
SHIGA TOXIN
C
1 2
SHIGA TOXIN
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
diarrheadigest@techlab.com | www.techlab.com
SPRING
2015
POOP CULTURE
Norovirus &
Gut Flora
An irregular publication of TECHLAB®, Inc.
dedicated to the etiology, diagnosis, and
therapy of diarrheal diseases and related
aspects of intestinal ecology
INSIDE
TECHLAB Diagnostics Go Global
Fecal Lactoferrin & C. difficile
Paleopathology News
Brought to you by the makers of the
enteric suite of rapid diagnostics
www.techlab.com | diarrheadigest@techlab.com
NEW FRONTIERS:
FECAL LACTOFERRIN
TESTING & C. DIFFICILE
TECHLAB produces Diarrhea
Digest twice annually. This
newsletter-style publication has
been a smash hit at tradeshows
and highlights developments in
enterics with a splash of humor.
Diarrhea
Digest
37. THE SPRING 2015 EDITION of
Diarrhea Digest, like all issues, blends
the humorous with the serious. Our back
page, called “Poop Culture” features funny
cartoons, amusing on-line links, trivia,
quizzes, and more, while the proceeding
pages focus on developments in intestinal
disease diagnostics.
38.
39. TECHLAB partners with health research organizations to make our products
available for clinical and epidemiological studies of diarrheal diseases.
With a grant from the Bill & Melinda Gates Foundation, the University
of Maryland School of Medicine’s Center for Vaccine Development used
TECHLAB diagnostics for a three-year study of diarrheal diseases among
young children in developing areas of Africa and Asia.
TECHLAB has also supplied diagnostics tests to the Global Enteric Multi-
Center Study (GEMS), the most extensive study of childhood diarrheal
diseases ever conducted, and to The International Centre for Diarrhoeal
Disease Research—a health research institution in Dhaka, Bangladesh.
The Global Enteric Multi-Center Study (GEMS) is the most extensive
study of childhood diarrheal diseases ever conducted, with more than
22,000 subjects from seven sites. Researchers evaluated about 40
pathogens to determine the most common causes of diarrheal diseases.
October 31, 2014
Bill and Melinda Gates
Co-Chairs, Bill and Melinda Gates Foundation
500 Fifth Avenue North
Seattle, WA 98109
Dear Mr. and Ms. Gates:
On behalf of the owners and employees of TECHLAB, Inc., we cordially invite you to visit TECHLAB’s
exhibit at the 63rd Annual Meeting of The American Society of Tropical Medicine and Hygiene held in
New Orleans between November 2-5, 2014.
TECHLAB’s theme for this year’s meeting is “Infectious Disease Diagnostics for Global Health.” In part,
this celebrates productive collaborations between the Bill and Melinda Gates Foundation and TECHLAB
over the last decade. These collaborations include the following:
• Utilization of TECHLAB’s enteric parasitology diagnostics in the Foundation’s GEMS project.
Importantly, GEMS documented a previously unknown level of mortality due to cryptosporidiosis.
• Participation in the Foundation’s MAL-ED project, both with enteric parasitology diagnostics and
biomarker assays that quantify intestinal inflammation in malnourished children.
• Involvement in the Foundation’s vaccine efficacy study, PROVIDE. TECHLAB partnered with Dr.
William A. Petri, Jr. at the University of Virginia to develop a novel biomarker assay that describes the
burden of tropical enteropathy in vaccine non-responders.
• Ongoing product development associated with the Foundation’s RIAT project that funds new
diagnostic assays to describe population-level success of vaccination campaigns.
• Participation in the Foundation’s newly formed Cryptosporidium intervention initiative.
The Bill and Melinda Gates Foundation has allowed TECHLAB to employ our strengths towards
improving global health; we look forward to expanding these collaborations in the near future.
We certainly understand that you have a very busy schedule. If the opportunity arises, however, we
would enjoy having you and your colleagues visit our ASTMH exhibit at BOOTH #113.
Sincerely,
Joel Herbein, PhD David Lyerly, PhD
Senior Research Scientist Vice President of Research and Development
Director, Veterinary Products Co-Owner
540-449-4556 (mobile)
jherbein@techlab.com
CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS
2001 Kraft Drive | Blacksburg, VA 24060-6358 | T: (540) 953-1664 | F: (540) 953-1665 | www.techlab.com | techlab@techlab.com
Infectious Disease
DIAGNOSTICS FOR GLOBAL HEALTH
INVITATION TO THE GATES
FOUNDATION to visit the TECHLAB
booth at ASTMH 2014.
A MAP showing the usage of
TECHLAB’s parasitology products
around the world.
RESEARCHERS AND STUDY
PARTICIPANTS from projects in
Bangladesh and Mali.
International
Collaborations & Grant
Funded Clinical Studies
40. Running a business and providing
employment allows us to connect
and contribute to the New
River Valley, the beautiful place
TECHLAB is proud to call home.
Beyond day-to-day business,
TECHLAB is always looking for
ways to reach out and connect
with the local community.
Community
Relations
IN OCTOBER 2014, TECHLAB
PARTICIPATED IN VIRGINIA’S
FIRST ANNUAL SCIENCE FESTIVAL
WEEK by holding an open house for
local science teachers. The event
allowed TECHLAB researchers to show
teachers how scientific principles are
used to develop medical diagnostic
products. (far left)
TECHLAB SPONSORED TEAM
‘WalkScan’ from Australia during
Virginia Tech Knowledge Works Global
Challenge in August. (near left)
TECHLAB RESEARCHERS
PRESENTED DATA at the VaBio
Poster Session. (far and near left)
41. NRVNEWS.COM, a local news outlet,
covered the release of our newest product
last fall, the E. Histolytica QUIK CHEK.
THE ROANOKE TIMES ONLINE COVERAGE
of our Fall 2014 BioTeach event.
News coverage helps to build
strong community ties and fosters
a sense of pride among TECHLAB
employees. When regional news
outlets cover TECHLAB efforts,
they help us to share the stories
beyond our product lines.
THE AWARD-WINNING REGIONAL
MAGAZINE THE ROANOKER featured
TECHLAB in an article about businesses with
global reach located in the Roanoke and New
River Valleys.
Regional
Press
42. Increasing brand recognition in
a competitive marketplace is not
easy. We put our logo on give-
away products that last, like cloth
bags, t-shirts, and tumblers, and
fun items, like squishy toilets, to
connect, create a dialog, and
resonate with our customers.
Promotional
Items
MISCELLANEOUS ITEMS including
our popular 25th anniversary t-shirt,
mesh bag, and tumbler.
OUR CUSTOM TUMBLER is
appreciated by our customers and our
staff alike.
A REUSABLE MESH BAG is a
popular giveaway at events.
OUR BRANDED SQUISHY TOILET
has been a smash hit at trade shows
and features our “unofficial” tagline: #1
in the #2 business.
